TFA Therapeutics annual total assets
2021
2022
2023
2024
2025
TFA Therapeutics Total Assets Growth & History (RAJAF)
TFA Therapeutics's total assets was $4.7M for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.7M | $33,807 | +0.73% |
| 2024 | 2024-12-31 | $4.6M | $1.3M | +37.95% |
| 2023 | 2023-12-31 | $3.4M | $1.2M | +59.24% |
| 2022 | 2022-12-31 | $2.1M | −$1.2M | −35.49% |
| 2021 | 2021-12-31 | $3.3M | — | — |
TFA Therapeutics quarterly total assets
Q4.21
Q4.22
Q3.23
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $4.7M | $33,807 | +0.73% |
| Q4 2024 | 2024-12-31 | $4.6M | $1.3M | +37.95% |
| Q4 2023 | 2023-12-31 | $3.4M | $1.2M | +59.24% |
| Q3 2023 | 2023-09-30 | $1.8M | — | — |
| Q4 2022 | 2022-12-31 | $2.1M | −$1.2M | −35.49% |
| Q4 2021 | 2021-12-31 | $3.3M | — | — |
TFA Therapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's total assets increased from $3.3M to $4.7M, a change of $1.4M. The latest reported quarter, Q4 2025, shows $4.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗